Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
Status:
Completed
Trial end date:
2019-01-29
Target enrollment:
Participant gender:
Summary
The purpose of this randomised, double-blind, placebo-controlled, parallel group study is to
assess the safety and efficacy of orally administered DS102 capsules versus placebo in the
treatment of adult patients with Chronic Obstructive Pulmonary Disease (COPD).